ACS chemical neuroscience spotlight on CEP-1347

ACS Chemical Neuroscience

Volumn 2, Issue 1, 2011, Pages 3-4

  Sweeney, Zachary K ^a   Lewcock, Joseph W ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; CEP 1347; DOPAMINE; DOPAMINE TRANSPORTER; K 252A; MIXED LINEAGE KINASE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CLINICAL TRIAL (TOPIC); COMPETITIVE INHIBITION; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; IMMUNOREACTIVITY; MOLECULAR DYNAMICS; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE;

ANIMALS; CARBAZOLES; CLINICAL TRIALS AS TOPIC; HUMANS; MAP KINASE SIGNALING SYSTEM; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; SOCIETIES, SCIENTIFIC;

EID: 78751671550     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn1000793     Document Type: Article

References (8)

1. Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., and Flavell, R. A. (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 101 (2) 665-70
2. Maroney, A. C., Finn, J. P., Connors, T. J., Durkin, J. T., Angeles, T., Gessner, G., Xu, Z., Meyer, S. L., Savage, M. J., Greene, L. A., Scott, R. W., and Vaught, J. L. (2001) Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family J. Biol. Chem. 276 (27) 25302-8
3. Harris, C. A., Deshmukh, M., Tsui-Pierchala, B., Maroney, A. C., and Johnson, E. M., Jr. (2002) Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons J. Neurosci. 22 (1) 103-13
4. Saporito, M. S., Brown, E. M., Miller, M. S., and Carswell, S. (1999) CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo J. Pharmacol. Exp. Ther. 288 (2) 421-7
5. Saporito, M. S., Hudkins, R. L., and Maroney, A. C. (2002) Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases Prog. Med. Chem. 40, 23-62
6. Parkinson Study Group (2004) The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD Neurology 62 (2) 330-2
7. The Parkinson Study Group PRECEPT Investigators (2007) Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease Neurology 69 (15) 1480-90
8. Dawson, T. M., Ko, H. S., and Dawson, V. L. (2010) Genetic animal models of Parkinson's disease Neuron 66 (5) 646-61